Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Norton Rose Fulbright Canada LLP
Last year, M&A activity in the U.S. healthcare and life sciences sector saw a decrease in both deal number and deal value when compared with 2012.
MNP
In a context of weak growth, consolidation and maturity (see previous blog: Dynamics of the food and beverage manufacturing sector in Quebec: the retailer perspective), what are retailers doing to differentiate themselves and address their shareholders’ concerns?
Torys LLP
On June 16, 2014, amendments to Bill C-17, Protecting Canadians from Unsafe Drugs Act (the Bill), were announced.
McCarthy Tétrault LLP
On June 20, 2014, the B.C. Government announced a host of new liquor laws that will be of interest to B.C. employers.
McMillan LLP
Medical marijuana has been making headlines in Canada after sweeping changes to regulations created a new market for commercial marijuana production.
Norton Rose Fulbright Canada LLP
Bill C-17, An Act to Amend the Food and Drugs Act, was introduced into Parliament by the Minister of Health on December 6, 2013.
Borden Ladner Gervais LLP
Currently, a community care access centre is defined as an approved agency that provides homemaking, personal support and professional services.
Gowling Lafleur Henderson LLP
"Personalized medicine," in its broadest aspects, is essentially the tailoring of treatments to individual characteristics, needs and preferences.
Borden Ladner Gervais LLP
While overall venture capital financing in Canada is on the rise compared to past years, life science start-ups are not experiencing the same increase.
Borden Ladner Gervais LLP
Canada has a regulatory regime that can affect the pricing of both small molecule and biologic medicines.
Borden Ladner Gervais LLP
In Canada, the sale and marketing of pharmaceuticals, biologics, medical devices and other healthcare products are regulated under the Food & Drugs Act.
Norton Rose Fulbright Canada LLP
In July 2013, new regulations relating to the use and production of medical marihuana came into force. The Marihuana for Medical Purposes Regulations (MMPR) significantly overhaul the previous statutory regime regulating medical marihuana in Canada.
MNP
When you pick up a newspaper, you’re bound to find something related to Canada’s or a specific province or territory’s health system.
Borden Ladner Gervais LLP
Canadian examiners’ objections to claims in which the examiner argues that there is not full support for the claims in the description have become increasingly common.
Borden Ladner Gervais LLP
Prospective patentees in the antibody arts in Canada have long faced objections to claims that cover antibodies different from those exemplified in their applications.
Borden Ladner Gervais LLP
The Proof of Principle POP grant program administered through the Canadian Institutes of Health Research (CIHR) has been in place since 2001.
Norton Rose Fulbright Canada LLP
The Competition Bureau announced in May 2014 that it was dropping its investigation into the life cycle management strategy used by Alcon Canada Inc.
Gowling Lafleur Henderson LLP
Canada provides data protection for "innovative drugs" for a term of eight years.
Gowling Lafleur Henderson LLP
The past year has seen significant evolution in the Canadian law of generic pharmaceutical damages claims under the Patented Medicines (NOC) Regulations.
MNP
Food and beverage manufacturing is one of the most important sectors in Canada and the rest of the world, both in terms of economic value and jobs.
Latest Video
Most Popular Recent Articles
McMillan LLP
Medical marijuana has been making headlines in Canada after sweeping changes to regulations created a new market for commercial marijuana production.
Borden Ladner Gervais LLP
Currently, a community care access centre is defined as an approved agency that provides homemaking, personal support and professional services.
Borden Ladner Gervais LLP
While overall venture capital financing in Canada is on the rise compared to past years, life science start-ups are not experiencing the same increase.
Bereskin & Parr LLP
Typically, the threshold of utility is easily met for inventions that have commercial applicability, such as a drug candidate.
Norton Rose Fulbright Canada LLP
Bill C-17, An Act to Amend the Food and Drugs Act, was introduced into Parliament by the Minister of Health on December 6, 2013.
Davis LLP
As you’re probably already well aware, the government of BC has been undergoing its first major review of our antiquated liquor laws in over two decades.
Torys LLP
On June 16, 2014, amendments to Bill C-17, Protecting Canadians from Unsafe Drugs Act (the Bill), were announced.
Gowling Lafleur Henderson LLP
"Personalized medicine," in its broadest aspects, is essentially the tailoring of treatments to individual characteristics, needs and preferences.
Borden Ladner Gervais LLP
Companies seeking to do business in North America should consider the many benefits of doing business in Canada.
McCarthy Tétrault LLP
On June 20, 2014, the B.C. Government announced a host of new liquor laws that will be of interest to B.C. employers.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners